Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Haatch Ventures
Haatch EIS Fund
26th Sep 2023
Apax Global Alpha
Resilience in face of rising interest rates
25th Sep 2023
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
81: Why investor concerns over hardware are overblown | Damon Bonser of British Design Fund
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
City of London Investment Group
Investment Companies
Positive markets offset by revenue margins
By
Dr Brian Moretta
01 Aug 2023
Shield Therapeutics Plc
Life Sciences
Accrufer Rx momentum gathering
25 Jul 2023
Stay up-to-date with the latest research
Sign up to our newsletter
Technology
The AI revolution – An introductory guide from a UK stock market perspective
By
Richard Jeans
18 Jul 2023
UK/OK-Muddling through
17 Jul 2023
ICG Enterprise Trust
Investment Companies
Investor Day – defensive growth in practice
By
Mark Thomas
10 Jul 2023
International Biotechnology Trust
Life Sciences
Industry M&A remains a key driver
By
Dr Martin Hall
10 Jul 2023
Apax Global Alpha
Investment Companies
2023 Capital Markets Day: accessing hidden gems
By
Mark Thomas
05 Jul 2023
The Monthly: July 2023
03 Jul 2023
NB Private Equity Partners
Investment Companies
Co-investments generating superior performance
By
Mark Thomas
16 Jun 2023
Real Estate Credit Investments (RECI)
Investment Companies
Double tangible security
By
Mike Foster
13 Jun 2023
Utilities
UK Water – Making Waves
By
Nigel Hawkins
08 Jun 2023
Prev
1
2
3
4
...
70
Next
